| 1 | [SID85273720] | Active | AC50 | 0.26 | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_Dose_CherryPick_Activity [AID652057, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | AC50 | 0.26 [uM] | | BioAssay | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_Dose_CherryPick_Activity | | AID | 652057 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID85273720] | Active | AC50 | 0.26 | Cell fusion assay for clade C HIV-1ZM109 Env Measured in Cell-Based System Using Plate Reader - 7013-05_Inhibitor_Dose_CherryPick_Activity [AID652058, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | AC50 | 0.26 [uM] | | BioAssay | Cell fusion assay for clade C HIV-1ZM109 Env Measured in Cell-Based System Using Plate Reader - 7013-05_Inhibitor_Dose_CherryPick_Activity | | AID | 652058 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID85273720] | Active | AC50 | 0.26 | HIV-1 Cell Fusion assay for clade B Env AD8 Measured in Cell-Based System Using Plate Reader - 7013-04_Inhibitor_Dose_CherryPick_Activity [AID652062, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | AC50 | 0.26 [uM] | | BioAssay | HIV-1 Cell Fusion assay for clade B Env AD8 Measured in Cell-Based System Using Plate Reader - 7013-04_Inhibitor_Dose_CherryPick_Activity | | AID | 652062 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID85273720] | Active | AC50 | 0.26 | Control Cell Fusion Counterscreen Assay Measured in Cell-Based System Using Plate Reader - 7013-02_Inhibitor_Dose_CherryPick_Activity [AID652040, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | AC50 | 0.26 [uM] | | BioAssay | Control Cell Fusion Counterscreen Assay Measured in Cell-Based System Using Plate Reader - 7013-02_Inhibitor_Dose_CherryPick_Activity | | AID | 652040 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID85273720] | Active | EC50 | 0.65873 | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624503, Type: confirmatory] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | EC50 | 0.65873 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624503 | | BioAssay type | confirmatory | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 6 | [SID85273720] | Active | EC50 | 0.65873 | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624503, Type: confirmatory] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | EC50 | 0.65873 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624503 | | BioAssay type | confirmatory | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 7 | [SID85273720] | Active | IC50 | 1.27 | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media [AID449762, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | IC50 | 1.27 [uM] | | BioAssay | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media | | AID | 449762 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID85273720] | Active | AC50 | 1.353 | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504941, Type: confirmatory] | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | AC50 | 1.353 [uM] | | BioAssay | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504941 | | BioAssay type | confirmatory | | Target | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] | | PubMed | | | Data Table |  |
|
| 9 | [SID85273720] | Active | IC50 | 1.93 | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol [AID449764, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | IC50 | 1.93 [uM] | | BioAssay | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol | | AID | 449764 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID85273720] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID85273720] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID85273720] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID85273720] | Active | Potency | 6.5131 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | Potency | 6.5131 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 14 | [SID85273720] | Active | Potency | 6.5131 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | Potency | 6.5131 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID85273720] | Active | Potency | 6.5131 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | Potency | 6.5131 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID85273720] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 17 | [SID85273720] | Active | Potency | 10 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 18 | [SID85273720] | Active | Potency | 10 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 19 | [SID85273720] | Active | AC50 | 11.782 | Bacterial Growth Inhibition Counterscreen using BacTiter-Glo Measured in Microorganism System Using Plate Reader - 2093-02_Inhibitor_Dose_CherryPick_Activity [AID504843, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | AC50 | 11.782 [uM] | | BioAssay | Bacterial Growth Inhibition Counterscreen using BacTiter-Glo Measured in Microorganism System Using Plate Reader - 2093-02_Inhibitor_Dose_CherryPick_Activity | | AID | 504843 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID85273720] | Active | CC50 | 28.963 | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis [AID435019, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | CC50 | 28.963 [uM] | | BioAssay | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis | | AID | 435019 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID85273720] | Active | AC50 | 61.18 | CEM21 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7013-03_Inhibitor_Dose_CherryPick_Activity [AID652042, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | AC50 | 61.18 [uM] | | BioAssay | CEM21 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7013-03_Inhibitor_Dose_CherryPick_Activity | | AID | 652042 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID85273720] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 23 | [SID85273720] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 24 | [SID85273720] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 25 | [SID85273720] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 26 | [SID85273720] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 27 | [SID85273720] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 28 | [SID85273720] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 29 | [SID85273720] | Active | | | Counterscreen for AddAB inhibitors: absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of bacterial viability [AID488956, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Counterscreen for AddAB inhibitors: absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of bacterial viability | | AID | 488956 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID85273720] | Active | | | Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput screening assay to identify activators of the GAA30 frataxin promoter [AID588350, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput screening assay to identify activators of the GAA30 frataxin promoter | | AID | 588350 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID85273720] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the GAA850 frataxin (FXN) promoter [AID588351, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the GAA850 frataxin (FXN) promoter | | AID | 588351 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID85273720] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID85273720] | Active | | | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability [AID449728, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability | | AID | 449728 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID85273720] | Active | | | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity [AID651610, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651610 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID85273720] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 36 | [SID85273720] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 37 | [SID85273720] | Active | | | TRFRET-based biochemical high throughput confirmation assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID602124, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | TRFRET-based biochemical high throughput confirmation assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 602124 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 38 | [SID85273720] | Active | | | TRFRET-based biochemical high throughput confirmation assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID602124, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | TRFRET-based biochemical high throughput confirmation assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 602124 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 39 | [SID85273720] | Active | | | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex [AID435030, Type: screening] | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex | | AID | 435030 | | BioAssay type | screening | | Target | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] | | PubMed | | | Data Table |  |
|
| 40 | [SID85273720] | Active | | | Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex [AID488942, Type: screening] | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex | | AID | 488942 | | BioAssay type | screening | | Target | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] | | PubMed | | | Data Table |  |
|
| 41 | [SID85273720] | Active | | | Counterscreen for RECBCD inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of AddAB recombination protein complex [AID651984, Type: screening] | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Counterscreen for RECBCD inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of AddAB recombination protein complex | | AID | 651984 | | BioAssay type | screening | | Target | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] | | PubMed | | | Data Table |  |
|
| 42 | [SID85273720] | Active | | | uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493011, Type: screening] | APOBEC3A gene product [Homo sapiens] [gi:21955158] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493011 | | BioAssay type | screening | | Target | APOBEC3A gene product [Homo sapiens] [gi:21955158] | | PubMed | | | Data Table |  |
|
| 43 | [SID85273720] | Active | | | Single concentration confirmation of uHTS for APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493151, Type: screening] | APOBEC3A gene product [Homo sapiens] [gi:21955158] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493151 | | BioAssay type | screening | | Target | APOBEC3A gene product [Homo sapiens] [gi:21955158] | | PubMed | | | Data Table |  |
|
| 44 | [SID85273720] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A) [AID623877, Type: screening] | Ano1 gene product [Mus musculus] [gi:334278898] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A) | | AID | 623877 | | BioAssay type | screening | | Target | Ano1 gene product [Mus musculus] [gi:334278898] | | PubMed | | | Data Table |  |
|
| 45 | [SID85273720] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624381, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624381 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 46 | [SID85273720] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624381, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624381 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 47 | [SID85273720] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 48 | [SID85273720] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 49 | [SID85273720] | Active | | | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity [AID488895, Type: screening] | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488895 | | BioAssay type | screening | | Target | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] | | PubMed | | | Data Table |  |
|
| 50 | [SID85273720] | Active | | | Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD [AID488955, Type: screening] | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 85273720 | | CID | 44246707 | | Outcome | Active | | BioAssay | Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD | | AID | 488955 | | BioAssay type | screening | | Target | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] | | PubMed | | | Data Table |  |
|